Digital Liver Cancer Summit 2021: New follow-up data from a landmark study of liver cancer patients treated with a combination of atezolizumab and bevacizumab has shown the longest ever survival time in a frontline phase 3 trial of systemic therapy…
Digital Liver Cancer Summit 2021: A global survey assessing the impact of COVID-19 on liver cancer has revealed delays in the screening, diagnosis, and treatment of the disease, with experts issuing stark warnings on liver cancer survival rates. February 5,…
Digital Liver Cancer Summit 2021: As the latest data suggests, liver cancer is now the third-most deadly cancer in the world, claiming nearly 1 million lives in 2020, the liver community takes robust action to tackle the burden posed by…
In memoriam: Prof. Wolfgang Gerok (1926–2021) and Prof. Roberto Groszmann (1939–2021) 20 January 2021 EASL is greatly saddened to hear of the passing earlier this week of two giants of hepatology, Prof. Wolfgang Gerok (1926–2021) and Prof. Roberto Groszmann (1939–2021).…
This year has been unlike any other. COVID-19 brought unimaginable challenges to the medical community, placing you at the forefront of the pandemic. The year 2020 posed unique questions to those of us treating liver patients and focusing on liver diseases. …
16 November 2020 Awareness Week on Alcohol-Related Harm (AWARH) takes place yearly. It serves to raise awareness among EU policymakers of the types of harm caused by alcohol, to increase awareness about the need to address alcohol-related harm in Europe,…
An extraordinary year, such as 2020, calls for increased connection with and accountability to our community. EASL wants to hear from you, our members, about what you want and need from us as a professional association, at the Extraordinary General…
On 4 November 2020, EASL held its first online Patient Forum, a vibrant exchange exploring synergies between our association of professionals and regional patient organisations engaged in the fight against liver disease. Scientists, practitioners, and patient advocates discussed two EASL…
Save the date and register for the first webinar. Free access. Topic: Sarcopenia in chronic liver disease When: Thursday, 12th Nov. 2020 from 8 pm to 9.30 pm CET Learning objectives: To gain an understanding of the pathophysiology of sarcopenia…
From ground-breaking discoveries to the Nobel Prize 2020, hepatology is cutting edge. This autumn, EASL has a crop of exciting fellowships on offer, to foster the next generation of bright minds. Are you a young scientist on a dynamic career…